About Deepbridge Life Sciences EIS

The Deepbridge Life Sciences EIS invests in growth-focused life-sciences companies, with Deepbridge taking an active role in guiding and mentoring the management team of the businesses it invests in. The investment strategy is to invest in a diversified portfolio of companies in the biopharmaceuticals, biotechnology and medical-technology sectors. The EIS has a target portfolio size of eight companies and a minimum subscription of £10,000. The target return is £1.70 for every £1 invested.

Deepbridge Life Sciences EIS Summary

Fund Manager: Deepbridge Capital
Tax Efficiency: EIS
Sector Focus: Biotech, Medtech, and Pharma
Stage Focus: Early-stage
Target Portfolio Size: 8 companies
Minimum Subscription: £10,000
Closing Date: Evergreen
Website: Learn more about Deepbridge Life Sciences EIS

About Deebridge Capital

Launched in 2010, Deepbridge helps build growth businesses, along with a network of investors, technology advisers and industry partners. To date, it has helped to create more than 300 jobs through its investments into companies.

Deepbridge focuses on the technology, life sciences and renewable-energy sectors. It looks for businesses that are innovative and scalable, with the potential to be global; able to demonstrate customer interest and market traction; and which have an energetic and experienced management team.

Contact Deepbridge Capital

Please note: SyndicateRoom is not affiliated with Deepbridge Life Sciences EIS. This page is for informational purposes only, and is the result of research conducted by SyndicateRoom. Whilst every effort has been taken to ensure accuracy at the time of publication this cannot be guaranteed and information is liable to change. Information displayed is neither a recommendation to invest or not, nor advice. With investments, your capital is at risk. SyndicateRoom is not responsible for the content of any external websites linked to from this page.

Are you the fund manager? Email [email protected] with any comments or amends.